NL-OMON35081
Withdrawn
N/A
The role of imaging in Parkinson*s disease subtypes: a pilot study . - Imaging in Parkinson*s disease subtypes.
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 10
- Status
- Withdrawn
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •PD patients must fulfill the United Kingdom Parkinson\*s Disease Society Brain Bank criteria for idiopathic PD.
- •PD patients must be allocated to subtype 4 based on their clinical scores.
- •A minimum age of 18 years is required for both patients and control subjects.
Exclusion Criteria
- •Control subjects with a disease of the central nervous system.
- •Participants with a contraindication for MRI.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not Yet Recruiting
N/A
11C-preladenant imaging in Parkinson's diseaseParkinson's diseaseJPRN-UMIN000038507Tokyo Metropolitan Institute of Gerontology20
Completed
N/A
Imaging Biomarkers in Parkinson s DiseaseParkinson DiseaseNCT01496599National Institute of Neurological Disorders and Stroke (NINDS)62
Active, Not Recruiting
Phase 1
Parkinson’s Disease: PET scan and evaluation of memantines pharmacological effect.(Parkinsons sygdom bedømt med PET skanning, herunder memantins farmakologiske effekt.) - N/AEUCTR2004-004139-74-DKeurologisk afdeling F12
Recruiting
N/A
Structural and functional MRI in Parkinson*s disease and healthy carriers with GBA mutation, an exploratory studyNL-OMON49472Radboud Universiteit Nijmegen80
Withdrawn
N/A
Molecular and Functional Imaging in SNCA, Parkin and PINK1Parkinson DiseasePARK1PARK2NCT04084509King's College London